Klin Farmakol Farm. 2013;27(2):89-91

Indocyanine green: properties, current use and tTrends in clinical practice

Roman Kufa
Chirurgická klinika 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Motol, Praha

Indocyanine green (ICG) is one of the types of fluorescent dyes (fluorophores, fluorochromes). It is a chemical compound containing

a reactive group capable of reacting with nucleophilic groups. The principle of fluorescence is the emission of energy in a very short time,

caused by the effect of radiation. Each fluorescent substance is characterized by two types of spectra – an excitation and an emission

spectrum. ICG has an excitation and emission spectrum in the near infrared region, hence the so-called NIR (near infrared) fluorophores.

ICG is the only NIR dye that has been certified by the FDA (U.S. Food and Drug Administration) for use in biomedicine since 1959

(1). Especially in recent years, indocyanine green has received a lot of attention due to its ever-expanding indications for use in clinical

medicine. It has been traditionally used in ophthalmology to diagnose diseases of the retina as well as to determine cardiac output and to

measure liver function. However, it is also used in surgical oncology to detect sentinel nodes and in neurosurgery, vascular surgery or

reconstructive surgery to evaluate microcirculation following free tissue transfer.

The article presents an overview of the basic chemical and physical properties of the substance and the possibilities for its use in clinical

applications.

Keywords: indocyanine green, ICG; fluorescence, infrared region, visualization, angiography

Published: July 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kufa R. Indocyanine green: properties, current use and tTrends in clinical practice. Klin Farmakol Farm. 2013;27(2):89-91.
Download citation

References

  1. Indocyanine_green [online], poslední aktualizace 1. 12. 2012; 3: 46 [cit. 1.1.2013], Wikipedie. Dostupné na: <http://en.wikipedia.org/wiki/Indocyanine_green>.
  2. Landsman ML, Kwant G, et al. Light-absorbing properties, stability, and spectral stabilization of indocyanine green. J Appl Physiol 1976; 40: 575-583. Go to original source... Go to PubMed...
  3. Maarek JMI, Holschneider DP, at al. Fluorescence of indocyanine green in blood: intensity dependence on concentration and stabilization with sodium polyaspartate. J Photochem Photobiology 2001; 65: 157-164. Go to original source... Go to PubMed...
  4. Benson RC, Kues HA. Fluorescence properties of indocyanine green as related to angiography. Phys Med Biol 1978; 23: 159-163. Go to original source... Go to PubMed...
  5. Mordon S, Devoisselle JM, et al. Indocyanine green: physicochemical factors affecting its fluorescencein vivo. Microvasc Res 1998; 55: 146-152. Go to original source... Go to PubMed...
  6. Yoneya S, Saito T, et al. Binding properties of indocyanine green in human blood. Invest Ophthalmol Vis Sci 1998; 39: 1286-1290. Go to PubMed...
  7. Engel E, Schraml R, et al. Light-induced decomposition of indocyanine green. Investigative Ophthalmology and Visual Science 2008; 49: 1777-1783. Go to original source... Go to PubMed...
  8. Hollins B, Noe B, et al. Fluorometric determination of indocyanine green in plasma. Clin Chem 1987; 33: 765-768. Go to original source...
  9. Laperche Y, Oudea MC, et al. Toxic effects of indocyanine green on rat liver mitochondria. Toxicology and applied pharmacology 1978; 41: 377-387. Go to original source... Go to PubMed...
  10. Paumgartner G. The handling of indocyanine green by the liver. Schweizerische Medizinische Wochenschrift 1975; 105: 30.
  11. Ogawa M, Kosaka N, et a. In vivo molecular imaging of cancer with a quenching nearinfrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Research 2009; 69: 1268-1272. Go to original source... Go to PubMed...
  12. Barth BM, Sharma R, et al. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers Invivo. ACS Nano 2010; 4: 1279-1287. Go to original source... Go to PubMed...
  13. Makino A, Kizaka-Kondoh S, et al. Near-infrared fluorescence tumor imaging using nanocarrier composed of poly (l-lactic acid) -block-poly (sarcosine) amphiphilic polydepsipeptide. Biomaterials 2009; 30: 5156-5160. Go to original source... Go to PubMed...
  14. Wolfe DR. Fluorescein angiography basic science and engineering. Ophthalmology 1986; 93: 1617-1620. Go to original source... Go to PubMed...
  15. Hayashi K, de Laey JJ. Indocyanine green angiography of submacular choroidal vessels in the human eye. Ophthalmologica 1985; 190: 20-29. Go to original source... Go to PubMed...
  16. Fox IJ, Brooker LG, et al. A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Proc Staff Meet Mayo Clin 1957; 32: 478-484. Go to PubMed...
  17. Flower RW, Hochheimer BF. Quantification of indicator dye concentration in ocular blood vessels. Exp Eye Res 1977; 25: 103-111. Go to original source... Go to PubMed...
  18. Baker KJ. Binding of sulfobromophthalein (BSP) sodium and indocyanine green (ICG) by plasma alpha-1 lipoproteins. Proc Soc Exp Biol Med 1966; 122: 957-963. Go to original source... Go to PubMed...
  19. Stanga PE, Lim JI, et al. Indocyanine green angiography in chorioretinal diseases: Indications and interpretation: An evidence-based update. Ophthalmology 2003; 110: 15-21. Go to original source... Go to PubMed...
  20. Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography and choroidal neovascularization. Retina 1992; 12 (3): 191-223. Go to original source...
  21. Fox IJ, Wood EH. Indocyanine green: physical and úhysiologic properties. Proc Mayo Clin 1960; 35: 732-744.
  22. Hajnal JV, Hill DLG, et al. Medical Image Registration, CRC Press, Boca Raton, Fla, USA, 2001. Go to original source...
  23. Woitzik J, Horn P, et al. Intraoperative control of extracranial-intracranial bypass patency by near-infrared indocyanine green videoangiography. J Neurosurg 2005; 102: 692-698. Go to original source... Go to PubMed...
  24. Pe?a-Tapia PG, Kemmling A, et al. Identification of the optimal cortical target point for extracranial-intracranial bypass surgery in patients with hemodynamic cerebrovascular insufficiency. J Neurosurg 2008; 108: 655-661. Go to original source... Go to PubMed...
  25. Haga S, Nagata S, et al. Near-infrared indocyanine green videoangiography for assessment of carotid endarterectomy. Acta Neurochir 2011; 153: 1641-1644. Go to original source... Go to PubMed...
  26. Kamp MA, Slotty P, et al. Microscope integrated quantitative analysis of intra-operative indocyanine green fluorescence angiography for blood flow assessment: first experience in 30 patients. Neurosurgery 2012; 70: 65-73. Go to original source... Go to PubMed...
  27. Desai ND, Miwa S, et al. Improving the quality of coronary bypass surgery with intra-operative angiography: validation of a new technique. J Am Coll Cardiol 2005; 46: 1521-1525. Go to original source... Go to PubMed...
  28. Reuthebuch O, Häussler A, et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest 2004; 125, 418-424. Go to original source... Go to PubMed...
  29. Balacumaraswami L, Taggart DP. Intraoperative imaging techniques to assess coronary artery bypass graft patency. Ann Thor Surg 2007; 83: 2251-2255. Go to original source... Go to PubMed...
  30. Unno N, Inuzuka K, et al. Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. J Vasc Surg 2007; 45: 1016-1021. Go to original source... Go to PubMed...
  31. Kang Y, Lee J, et al. Application of novel dynamic optical imaging for evaluation of peripheral tissue perfusion. Inter J Cardiol 2010; 145: 99-101. Go to original source... Go to PubMed...
  32. Kikuchi M, Hosokawa K. Visualized sclerotherapy of varicose veins. Derm Surg 2010; 36: 1050-1055. Go to original source... Go to PubMed...
  33. Mothes H, Dönicke T, et al. Indocyanine-green fluorescence video angiography used clinically to evaluate tissue perfusion in microsurgery. J Trauma 2004; 57(5): 1018-1024. Go to original source... Go to PubMed...
  34. Komorowska-Timek E, Gurtner GC. Intraoperative perfusion mapping with laser-assisted indocyanine green imaging can predict and prevent complications in immediate breast reconstruction. Plast Reconstr Surg 2010; 125: 1065-1073. Go to original source... Go to PubMed...
  35. Lim H, Soter N. Clinical Photomedicine. Marcel Dekker Inc., New York, NY USA 1993.
  36. Ohnishi S, Lomnes SJ, et al. Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 2005; 4: 172-181. Go to original source...
  37. Omar GS, Wilson M, et al. Lethal photosensitization of wound-associated microbes using indocyanine green and near-infrared light. BMC Microbiology 2008; 8: 111. Go to original source... Go to PubMed...
  38. Yanina IY, Bochko VA, et al. Optical image analysis of fat cells for indocyanine green mediated near-infrared laser treatment. Laser Physics Letters 2011; 8(9): 684-690. Go to original source...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.